Panretin

Product manufactured by Eisai Inc.

Application Nr Approved Date Route Status External Links
NDA020886 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Panretin® Gel Is Indicated For Topical Treatment Of Cutaneous Lesions In Patients With Aids-Related Kaposi’s Sarcoma. Panretin® Gel Is Not Indicated When Systemic Anti-Ks Therapy Is Required (E.g., More Than 10 New Ks Lesions In The Prior Month, Symptomatic Lymphedema, Symptomatic Pulmonary Ks, Or Symptomatic Visceral Involvement). There Is No Experience To Date Using Panretin® Gel With Systemic Anti-Ks Treatment.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alitretinoin ALITRETINOIN ZINC12661824

Comments